Consider Ethical Questions of 'Designer Babies'
By Elizabeth M. Meade,
The Morning Call
| 03. 10. 2014
A recent
New York Times article (Feb. 25) on a new fertility procedure that involves using the genetic material of three people to create a baby does a very good job of outlining the major ethical challenges posed by the technique.
The procedure is intended to produce children free of certain genetic defects, by replacing the mitochondria of the egg with the mitochondria of a donor who is free of the genetic defect. It could potentially be a godsend to families who risk passing certain catastrophic genetic defects on to their children. But, as The Times article rightly points out, it raises the ethical questions of whether we should be designing our children to be free of whatever we consider to be defects.
"Designer babies," as they are often called, represent both the best and worst of our understanding of parenthood. Several techniques already allow us to prevent passing genetic defects on to the next generation.
For years, fertility clinics have been able to screen embryos for genetic defects before implanting them; in some cases, halting or slowing the prevalence...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Evelina Johansson Wilén, Jacobin | 01.18.2026
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the one hand, it is deeply transformative, bodily alien, sometimes almost incomprehensible to the person undergoing it. On the other hand...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...